Fax: (011) 852-28199636
Original Article
You have full text access to this OnlineOpen article
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
Article first published online: 23 JUN 2009
DOI: 10.1002/cncr.24495
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Xu, M. Z., Yao, T.-J., Lee, N. P. Y., Ng, I. O. L., Chan, Y.-T., Zender, L., Lowe, S. W., Poon, R. T. P. and Luk, J. M. (2009), Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer, 115: 4576–4585. doi: 10.1002/cncr.24495
Publication History
- Issue published online: 17 SEP 2009
- Article first published online: 23 JUN 2009
- Manuscript Accepted: 13 FEB 2009
- Manuscript Revised: 22 JAN 2009
- Manuscript Received: 1 DEC 2008
Funded by
- Research Grants Council of Hong Kong. Grant Numbers: 772109M, 771607M
- Innovation and Technology Commission of the Hong Kong Government. Grant Number: ITS120/07
- Sun Chieh Yeh Research Foundation for Hepatobiliary and Pancreatic Surgery
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Deregulation of Hippo kinase signalling in Human hepatic malignancies, Liver International, 2012, 32, 1Direct Link:
- 2, , , , , Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012, 1826, 1, 215
- 3, , , , , , , , , , Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies, Human Pathology, 2012,
- 4, , Hippo signaling pathway in mammalsï¼a new therapeutic target for tumors, Hereditas (Beijing), 2012, 34, 3, 269
- 5, , , , , , , , The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 2012, 138, 4, 637
- 6, , The YAP and TAZ transcription coactivators: key downstream effectors of the mammalian Hippo pathway, Seminars in Cell & Developmental Biology, 2012,
- 7, , , , , , , , , , , YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes, Oncogene, 2012,
- 8, , , , , YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF5 Transcription Factor, The American Journal of Pathology, 2012, 180, 6, 2452
- 9, , , , , , , , , , A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription, Journal of Biochemistry, 2011, 150, 2, 199
- 10, , , , , , , , , , , , , , , , Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein–mediated activation, Hepatology, 2011, 54, 6Direct Link:
- 11, , , , , , , , , COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells, OMICS: A Journal of Integrative Biology, 2011, 15, 6, 383
- 12, , Hippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance, Journal of Genetics and Genomics, 2011, 38, 10, 471
- 13, Hippo signalling: Liver size regulation and beyond, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 5, 344
- You have free access to this content14, Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation, Pathology International, 2011, 61, 6Direct Link:
- 15, , , , Mammalian Hippo pathway: from development to cancer and beyond, Journal of Biochemistry, 2011, 149, 4, 361
- 16, , , Mitogen-activated protein kinases in hepatocellular carcinoma development, Seminars in Cancer Biology, 2011, 21, 1, 10
- 17, , , Strategies for hepatocellular carcinoma therapy and diagnostics: Lessons learned from high throughput and profiling approaches, Hepatology, 2011, 53, 6Direct Link:
- 18, , , The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal, Nature Cell Biology, 2011, 13, 8, 877
- 19, , , , , , , , The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene, Oncogene, 2011, 30, 25, 2810
- 20
- 21, , , , , , Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth, Journal of Neuropathology and Experimental Neurology, 2011, 70, 7, 568
- 22, , , , , , , , Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma, Oral Oncology, 2011, 47, 8, 693
- 23, , , , , , , , , Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice, Hepatology, 2011, 53, 6Direct Link:
- 24
- 25, , , , , , , , , , , AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma, Oncogene, 2010, 30, 10, 1229
- 26, , , , , , Cancer gene discovery in hepatocellular carcinoma, Journal of Hepatology, 2010, 52, 6, 921
- You have free access to this content27, Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells, Cancer Science, 2010, 101, 1Direct Link:
- 28, , , , , , , , , , , Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver, Proceedings of the National Academy of Sciences, 2010, 107, 4, 1437
- 29, , , , , , , , , , , , , , , , , , microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma, Molecular Systems Biology, 2010, 6,
- 30, , , MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties, Biochemical and Biophysical Research Communications, 2010, 394, 3, 623
- 31, , , , Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development, British Journal of Cancer, 2010, 104, 1, 24
- You have free access to this content32, , , , , , Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer, Cancer Science, 2010, 101, 5Direct Link:
- 33, The Hippo Signaling Pathway in Development and Cancer, Developmental Cell, 2010, 19, 4, 491
- 34, , , , , , , , , , , The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis, Proceedings of the National Academy of Sciences, 2010, 107, 18, 8248
- 35, , , , , , , , , , YAP is a candidate oncogene for esophageal squamous cell carcinoma, Carcinogenesis, 2010, 32, 3, 389
- 36

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)